Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

Por Tchoghandjian, A, Jennewein, C, Eckhardt, I, Momma, S, Figarella-Branger, D, Fulda, S
Publicado em 2014

Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica.

Por Lafforgue, P, Senbel, E, Figarella-Branger, D, Boucraut, J, Horschowsky, N, Pellissier, J F, Acquaviva, P C
Publicado em 1993

Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of susceptibility to malignant hyperthermia

Por Guis, S, Bendahan, D, Mattei, JP, Kozak-Ribbens, G, Figarella-Branger, D, Trefouret, S, Bernard, V, Lando, A, Cozzone, J
Publicado em 2003

HLA DRB101 and macrophagic myofasciitis

Por Guis, S, Pellissier, JF, Nicoli, F, Reviron, D, Mattei, JP, Gherardi, RK, Pelletier, J, Kaplanski, G, Figarella-Branger, D, Roudier, J
Publicado em 2003

P04.07 EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA

Por Tabouret, E., Tchoghandjian, A., Denicolai, E., Delfino, C., Metellus, P., Barrie, M., Boucard, C., Ouafik, L., Figarella-Branger, D., Chinot, O.
Publicado em 2014

P04.08 PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB)

Por Tabouret, E., Boudouresque, F., Denicolai, E., Barrié, M., Boucard, C., Metellus, P., Autran, D., Figarella-Branger, D., Ouafik, L., Chinot, O.
Publicado em 2014

P08.07 LEPTOMENINGEAL GLIOMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE STUDY OF 31 PATIENTS

Por Autran, D., Tabouret, E., Barrié, M., Boucard, C., Terciolo, A., Loundou, A., Metellus, P., Dufour, H., Figarella-Branger, D., Chinot, O.L.
Publicado em 2014

P17.20 PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA

Por De Cock, L., Sala, Q., Barrie, M., Boucard, C., Metellus, P., Tabouret, E., Padovani, L., Figarella-Branger, D., Dufour, H., Chinot, O.
Publicado em 2014

O10.02 MITOTIC INDEX, MICROVASCULAR PROLIFERATION AND NECROSIS DEFINE THREE GROUPS OF 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMAS ASSOCIATED WITH DIFFERENT GENOMIC ALTERATIONS

Por Figarella-Branger, D., Mokhtari, K., Dehais, C., Jouvet, A., Uro-Coste, E., Colin, C., Carpentier, C., Ducray, F., Idbaih, A., Network, French POLA
Publicado em 2014

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152

Por Tchoghandjian, A, Soubéran, A, Tabouret, E, Colin, C, Denicolaï, E, Jiguet-Jiglaire, C, El-Battari, A, Villard, C, Baeza-Kallee, N, Figarella-Branger, D
Publicado no Cell Death Dis (2016)

P17.01 CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY

Por Alentorn, A., Dehais, C., Carpentier, C., Mokhtari, K., Ducray, F., Figarella-Branger, D., Delattre, J., Idbaih, A., (POLA)”, POLA Network “Prise en charge des OLigodendrogliomes Anaplasiques
Publicado em 2014

Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002)

Por Frappaz, D, Chinot, O, Bataillard, A, Ben Hassel, M, Capelle, L, Chanalet, S, Chatel, M, Figarella-Branger, D, Guegan, Y, Guyotat, J, Hoang-Xuan, K, Jouanneau, E, Keime-Guibert, F, Laforêt, C, Linassier, C, Loiseau, H, Maire, J P, Menei, P, Rousmans, S, Sanson, M, Sunyach, M P
Publicado em 2003